Stoke Therapeutics Inc.

7.38
-0.47 (-5.99%)
At close: Mar 03, 2025, 3:59 PM
7.40
0.20%
After-hours: Mar 03, 2025, 04:00 PM EST

Stoke Therapeutics Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Cash & Equivalents 191.44M 113.56M 144.9M 287.31M 222.47M 105.4M 1.8M
Short-Term Investments 9.95M 116.04M 74.92M n/a n/a n/a n/a
Long-Term Investments n/a 569K 569K 205K 205K 204K 56K
Other Long-Term Assets 569K n/a n/a n/a n/a n/a n/a
Receivables 64K 588K 132K 6K 281K 196K n/a
Inventory n/a 10.93M n/a n/a n/a n/a n/a
Other Current Assets 13.88M 13.89M 9.28M 6.62M 6.56M 548K 113K
Total Current Assets 215.34M 244.07M 229.22M 293.93M 226.03M 106.14M 1.91M
Property-Plant & Equipment 12.43M 11.43M 9.08M 3.79M 2.51M 1.19M 473K
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 13M 12M 9.65M 4M 2.72M 1.4M 529K
Total Assets 228.34M 256.07M 238.87M 297.93M 228.75M 107.54M 2.44M
Account Payables 1.7M 766K 2.38M 1.5M 751K 1.07M 141K
Deferred Revenue 15.31M 14.88M 12.71M -1.07M n/a n/a -3M
Short-Term Debt 2.39M 2.36M 1.51M 1.07M n/a n/a 3M
Other Current Liabilities 11.75M 13.39M 13.25M 8.86M 3.35M 1.4M 574K
Total Current Liabilities 30.82M 31.39M 17.14M 11.43M 4.1M 2.47M 3.71M
Long-Term Debt n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities 4.88M 2.97M 3.95M 422K 221K 4K 16K
Total Long-Term Liabilities 37.96M 39.82M 3.95M 422K 221K 4K 16K
Total Liabilities 68.78M 71.22M 21.09M 11.85M 4.32M 2.47M 3.73M
Total Debt 2.06M 2.36M 1.51M 80K n/a n/a 3M
Common Stock 5K 4K 4K 4K 3K 1K 1K
Retained Earnings -401.85M -297.15M -196.08M -110.28M -58.03M -25.71M -13.19M
Comprehensive Income -24K -1.18M -168K -0.00 0.00 -379K -172K
Shareholders Equity 159.56M 184.85M 217.78M 286.08M 224.43M 105.07M -1.29M
Total Investments 9.95M 116.04M 74.92M 205K 205K 204K 56K